{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/643507e2c06561001184a9ab/64350987c06561001184f7a4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode 2: How can Fabry disease be managed?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/cover/1681196725107-653f086d637a81779a0bbbb0826d6dfc.jpeg?height=200","description":"<p>In this episode, Dr Charles Denaro from Australia and Dr Charles Lourenço from Brazil discuss Fabry disease management using various treatments. We find out how Fabry disease therapies work and how interventions should be tailored to meet the needs of individual patients.</p><p>&nbsp;</p><p>This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77421 (date of preparation: February 2023).</p>","author_name":"Takeda Pharmaceuticals"}